Cargando…
MET基因改变的非小细胞肺癌靶向治疗耐药机制及治疗策略
Mesenchymal to epithelial transition factor (MET) gene alterations involve in the proliferation, invasion, and metastasis of non-small cell lung cancer. MET-tyrosine kinase inhibitors (TKIs) have been approved to treat non-small cell lung cancer with MET alterations, and resistance to these TKIs is...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600752/ https://www.ncbi.nlm.nih.gov/pubmed/37985154 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.33 |